Work

Lysozyme nephropathy in chronic myelomonocytic leukemia

Year: 2019

Type: article

Abstract: Lysozyme nephropathy is a frequently unrecognized cause of renal disease in chronic myelomonocytic leukemia and may serve as a novel indication for treatment in this patient population. We demonstrate that in newly diagnosed CMML patients, plasma lysozyme levels are positively correlated with both absolute monocyte count and serum creatinine.

Source: Clinical Case Reports

DOI: 10.1002/ccr3.2188

Authors: Ami B. Patel, Rodney R. Miles, Michael W. Deininger

Institutions: University of Utah, ARUP Laboratories (United States)

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,100